By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Caladrius Biosciences (Formerly Known As NeoStem, Inc.)  

420 Lexington Ave, Suite 350

New York  New York  10170  U.S.A.
Phone: 212-584-4180 Fax: 425-696-4651




Company News
Caladrius Biosciences (CLBS) Receives FDA Fast Track Designation For CLBS03 To Treat Recent Onset Type 1 Diabetes 7/28/2016 10:18:05 AM
Caladrius Biosciences (CLBS) Announces 1-For-10 Reverse Split 7/27/2016 8:16:28 AM
Caladrius Biosciences (CLBS) To Present At Upcoming July Conferences 7/7/2016 8:46:23 AM
The Alliance for Regenerative Medicine (ARM) Welcomes New Chairman, Bob Preti, Ph.D., President Of PCT And SVP Of Caladrius Biosciences (CLBS) 6/28/2016 2:35:04 PM
Caladrius Biosciences (CLBS) Licenses Key Technology and Subleases Irvine Facility to AiVita Biomedical 5/26/2016 5:57:14 AM
Caladrius Biosciences (CLBS) Announces First Subject Treated In CLBS03 Type 1 Diabetes Phase II Trial 3/29/2016 8:06:07 AM
Caladrius Biosciences (CLBS) Announces Presentations At Upcoming Investor Conferences In February 1/28/2016 7:39:06 AM
Investors Unhappy as Caladrius Biosciences (CLBS) Kills Phase III Oncology Program, Lays Off 40 in SoCal 1/8/2016 6:37:36 AM
Caladrius Biosciences Announces Publication Of Two-Year Results From Phase 1 Trial Of Type 1 Diabetes Product Candidate In Science Translational Medicine 12/1/2015 10:25:37 AM
Caladrius Biosciences Presents Additional Data Supporting Lead Product Candidate For Metastatic Melanoma At SITC 2015 11/9/2015 11:44:14 AM